HS- BodyPROS
- Conditions
- L73.2Hidradenitis suppurativa
- Registration Number
- DRKS00031812
- Lead Sponsor
- Ruhr Universität Bochum
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 300
Confirmed HS diagnosis
- Over 18 years old
The following patients are excluded from the study:
- active tumour disease
- metastatic tumour disease
- Advanced liver disease
- liver insufficiency
- liver cirrhosis
- renal insufficiency
- Pregnancy or breastfeeding
- Patients under 18 years of age
- Patients without informed consent
- known acute or chronic infectious diseases
- insufficient language skills (German) to complete the questionnaires
- mental retardation
- infections or severe oedema in the lower leg area
Study & Design
- Study Type
- observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Is body composition related to disease severity of HS (Hurley classification, IHS4, SAHS, mHSS; 0 and 3 months after first presentation)?<br>Are there differences in body composition to patients with psoriasis and healthy controls vs. HS?
- Secondary Outcome Measures
Name Time Method - Is the frequency of certain body components associated with HS severity (Hurley classification, IHS4, SAHS, mHSS)?<br>- Is the relapse frequency of HS in the last 4 weeks dependent on body composition?<br>- Is the frequency of HS relapses in the last 4 weeks dependent on body composition?<br>- Is quality of life (DLQI) dependent on body composition?<br>- Can body composition modification reduce HS activity?<br>- What is the relationship between BMI and body composition in HS?<br>- Does poor body composition promote the development of secondary diseases (obesity, CHD, insulin resistance, diabetes mellitus)?<br>